Salesforce Inc (CRM)
Salesforce Inc. (NYSE: CRM) Price Prediction and Forecast 2025-2030 (July 2025)
Shares of Salesforce Inc. ( NYSE: CRM ) lost 1.58% over the past month, dragging down the stock's year-to-date loss to 18.61%.
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce?
VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.
Salesforce.com (CRM) Outperforms Broader Market: What You Need to Know
In the most recent trading session, Salesforce.com (CRM) closed at $267.22, indicating a +1.38% shift from the previous trading day.
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?
VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.
Salesforce vs. HubSpot: Which CRM Stock Is the Smarter Buy Now?
HUBS outpaces CRM in sales growth and market momentum, making it a better investment pick despite the premium.
Why Salesforce.com (CRM) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Salesforce: Undervalued And Ready To Rebound On A Likely Q2 Beat
After a prolonged correction, Salesforce is oversold. I think its AI growth engine, combining Agentforce and Data Cloud, is poised to re-accelerate top-line growth. I anticipate strong Q2 FY2026 results, driven by resilient demand and the successful integration of recent acquisitions. Wall Street has set a low bar for Q2 earnings, with consensus estimates below management's own guidance, creating a clear setup for a beat.
Is It Worth Investing in Salesforce.com (CRM) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Salesforce Bets Big on Agentforce: Can AI Agents Power Growth?
Agentforce platform hits $100 million ARR in two quarters as CRM ramps up AI agent adoption and integration.
Veeva Systems' Vault CRM Momentum Builds With Top Biopharma Adoptions
VEEV sees rising Vault CRM adoption among top biopharma firms, driven by new features, fueling customer migration and growth.
Salesforce Stock Set for 30% Upside to Reach New Highs
If you are wondering whether Salesforce NYSE: CRM can hit new highs this year, it can, at least according to what the analysts are saying. Their activity capped gains following the FQ1 release but has set this market up to rebound strongly, if not following the FQ2 release, then by the end of the fiscal year.
